QA: Tyra Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001863127_2023_Tyra_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0001863127, Tyra Biosciences Inc.

  xvar xval
0 AssetsCurrent 257,288,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,077,000
3 remainder_Assets 7,816,000
4 LiabilitiesCurrent 5,701,000
5 LiabilitiesNoncurrent 2,651,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,919,000
9 ResearchAndDevelopmentExpense 43,008,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,602,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 266,181,000
1 Liabilities 8,352,000
2 Expenses 58,927,000
3 Revenues 0
4 StockholdersEquity 257,829,000
5 NetIncome -55,325,000
6 ComprehensiveNetIncome -55,325,000
7 BaseVar 168,531,000
8 EconomicCapitalRatio 2.83

Edgar->Model Mapping

Feature Distribution

Change over Time